Capula Management Ltd Purchases New Shares in NeoGenomics, Inc. (NASDAQ:NEO)

Capula Management Ltd acquired a new position in NeoGenomics, Inc. (NASDAQ:NEO – Free Report) in the first quarter, according to its most recent disclosure with the Securities and Exchange Commission. The institutional investor acquired 31,840 shares of the medical research company’s stock, valued at approximately $554,000. A number of other institutional investors have also added […]

Related Keywords

United States ,Piper Sandler ,Raymond James ,Morgan Stanley ,Capula Management Ltd ,Emerald Mutual Fund Advisers ,Pharma Services ,Schroder Investment Management Group ,Nasdaq ,Millennium Management ,Norges Bank ,Neogenomics Inc ,Exchange Commission ,Dimensional Fund Advisors ,Clinical Services ,Free Report ,Mutual Fund Advisers Trust ,Fund Advisors ,Investment Management Group ,Genomics Trading Down ,Visit Holdingschannel ,Neogenomics Daily ,Neogenomics ,Nasdaq Neo ,Neo ,Medical ,Sec Filings ,13f ,Hedge Fund Holdings ,Institutional Investor Holdings ,